ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO048

Validation of Renal Angina Indices in Critically Ill Patients and Assessment of Urinary Biomarker Incorporation for AKI Prediction

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Zuñiga Gonzalez, Erick Yasar, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Villegas, Juan M., Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Del Toro-Cisneros, Noemi, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Ortega, Rosario Guadalupe Hernandez, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
  • Galindo, Pablo E., Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico City, Mexico
  • Cruz Rivera, Cristino, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
  • Vega, Olynka, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Ciudad de México, Mexico
Background

The renal angina index (RAI) helps to predict acute kidney injury (AKI) in critically ill patients. Moreover, whether incorporation of urinary biomarkers into RAI may enhance severe AKI prediction is not kown.

Methods

This was a prospective cohort of patients admitted in two intensive care units (ICU) at third-level hospitals in Mexico City. Demographic, laboratory data and urinary samples were collected at ICU admission. RAI score was calculated using three methods at Day0: Matsuura, Ortiz-Soriano and Del Toro-Cisneros methods. AKI was defined according to KDIGO guidelines. The study aimed to evaluate RAI's predictive ability for severe AKI (stage 2 or 3) at 24 and 72 hours post-admission.

Results

Of the 134 patients analyzed, nineteen presented a stage 2 or 3 AKI over 72 hr follow-up. After evaluating all indices, RAI Matsuura presented the best performance in receiver-operating characteristics (ROC) analysis (cutoff of 10p) at 24hr (AUC 0.74, 95% IC 0.57-0.90) and 72hr (AUC 0.70, 95% IC 0.56-0.84). Neither urinary neutrophil gelatinase-associated lipocalin (uNGAL) nor urinary heat shock protein-72 (uHsp72) incorporation into RAIs improved ROC curve and discrimination for RAIs. [Table 1]

Conclusion

Our study highlights RAIs as a practical and useful tool for assessment of AKI risk in ICU adult patients. Urinary biomarkers incorporation does not improve accuracy for prediction of severe AKI, promoting RAIs' seamless integration into routine clinical assessments

Performance of different renal angina indices with and w/o addition of uNGAL
 AUCSensitivitySpecificityPPVNPV
RAI Matsuura [cut-off 10p]
24hr
72hr

0.74 (0.57-0.90)
0.70 (0.56-0.84)

66%
57%

81%
82%

26%
35%

96%
92%
RAI +/ NGAL + *
24hr
72hr

0.66 (0.47-0.84)
0.65 (0.49-0.80)

60%
56%

72%
73%

17%
25%

95%
91%
RAI del Toro [cut-off 10p]
24hr
72hr

0.68 (0.53-0.83)
0.69 (0.56-0.81)

75%
73%

61%
63%

16%
25%

96%
94%
RAI +/ NGAL +*
24hr
72hr

0.70 (0.54-0.86)
0.68 (0.54-0.82)

60%
75%

72%
68%

16%
24%

95%
94%
RAI Ortiz-Soriano [cut-off 10p]
24hr
72hr

0.62 (0.47-0.77)
0.60 (0.55-0.81)

79%
83%

43%
41%

18%
12%

92%
96%
RAI +/ NGAL +*
24hr
72hr

0.66 (0.50-0.80)
0.65 (0.52-0.78)

90%
88%

42%
44%

13%
19%

98%
96%

Predictive performance of RAIs for severe AKI (stage 2/3) at 24 and 72 hr. uNGAL cutoff based on Youden's optimal index: NGAL >152 ng/ml. *Patients included in the analysis n=118.